00010967529/302024FYFALSEiso4217:USDxbrli:shares00010967522023-10-012024-09-3000010967522024-03-3100010967522024-10-31

美國

證券和交易委員會

華盛頓特區 20549

____________________________________

表格 10-K/A

(修訂版 1)

☒			根據1934年證券交易法第13或15（d）條款的年度報告

截至財政年度結束的2024年9月30日

or

☐			根據1934年證券交易法第13或15(d)節的轉型報告書

 對於從_______________到_______________的過渡期

委員會文件號 001-15401

益泰威個人護理公司

(根據其章程規定的註冊人準確名稱)

密蘇里

43-1863181

（設立或組織的其他管轄區域）

（美國國稅局僱主識別號碼）

6研究驅動

(203)

944-5500

Shelton,

康涅狄格州

06484

(註冊人電話號碼，包括區號)

（總部地址及郵政編碼）

在法案第12(b)條的規定下注冊的證券：

每個類別的標題			股票標的			在其上註冊的交易所的名稱
普通股，每股面值$0.01			紐交所			紐約證券交易所

根據該法案第12（g）條登記的證券：無。

標的標記，如果註冊人是根據證券法規405條規定的知名老手發行人，請打鉤。是 ☒否☐

如果註冊人不需要根據《法案》第13或15(d)條提交報告，請用勾號標記。 是 ☐ No ☒

請用勾號勾選以下內容：（1）在過去的12個月內（或者c註冊人所需要提交此類報告的更短期限內），c註冊人已經提交了根據1934年證券交易法第13或第15（d）條規定需要提交的全部報告；和（2）c註冊人在過去的90天內一直需要遵守此類提交要求。是 ☒否☐

請勾選是否註冊人已經按照《規則405》的規定，在過去12個月（或註冊人被要求提交和發佈這些文件的較短時間內）電子提交併在其公司網站上發佈了所有必需的互動數據文件。 是 ☒否☐

---

請勾選標記以說明註冊人是大型快速申報人、加速申報人、非加速申報人、較小的報告公司還是新興成長型公司。請查看《交易所法》第120億.2條中「大型快速申報人」、「加速申報人」、「較小的報告公司」和「新興成長型公司」的定義。

大型加速報告人

☒

加速文件提交人

☐

非加速文件提交人

☐

（如果是較小的報告公司，請勿選中）

較小的報告公司

☐

新興成長公司

☐

如果是新興增長企業，請勾選是否選擇不使用擴展過渡期，在符合交易所法第13(a)條規定的任何新的或修訂的財務會計準則的合規方面遵循。☐

請勾選標記，以指示註冊人是否已提交了《Sarbanes-Oxley法案》(15 U.S.C. 7262(b))下其內部控制的有效性的管理評估報告和證明報告，由準備或發佈其審計報告的註冊公共會計師事務所編制。☒

如果證券根據《證券法》第12(b)條登記，請勾選印記，以表示註冊人包括在文件中的財務報表反映了對之前發佈的財務報表的更正。☐

標明任何這些錯誤更正是否屬於重新陳述，是否要求對註冊人在有關恢復期間執行的任何高層管理人員激勵性報酬進行恢復分析。 ☐

請在 ☐ 中打勾，表示報告人不是殼公司（根據《法案第12b-2條款》的定義）。☐ 否 ☒

截至2024年3月31日，即註冊公司最近完成的第二個財政季度的最後一天，非關聯方持有的有投票權和無投票權普通股的總市值爲$1,871,912,250.

 

截至2024年10月31日，登記公司的普通股流通數量爲 48,721,170.

 

參考文件被引用

在2024年股東年會上，註冊人的最終代理聲明的某些部分將在2024年9月30日之後的120天內向證券交易委員會提交，並通過引用納入本報告的第三部分。

---

說明註釋

Edgewell個人護理公司（可以稱爲「公司」，「我們」，「我們」和「我們的」）正在提交《年度報告第1號修正案》，對我們截至2024年9月30日的《年度報告10-K表格》的第15項和展覽索引進行修正，該報告最初於2024年11月14日提交給美國證券交易委員會（「SEC」，即「原始10-K表格」），僅以包含第10.44、19.1、97.1和104號附件，這些附件在原始10-K表格中不小心遺漏，並根據1934年證券交易法修正案（「交易法」）第120億.15條款提交我們首席執行官和首席財務官的新認證作爲第31.3和31.4號附件。

除非另有規定，在此修改案中，本修改仍然適用於原始10-k表格的日期，並且公司尚未更新其中包含的披露以反映原始10-k表格日期之後發生的任何事件。因此，應與原始10-k表格以及我們向證券交易委員會提交的後續申報書一起閱讀。所有在此處使用但未定義的大寫詞彙應具有其在原始10-k表格中賦予的含義。

項目 15. 陳列品，財務報表附表。

作爲本報告的一部分提交的文件：

1)基本報表。

以下內容包括在原始10-k表格的第8條。基本報表和補充數據。

◦獨立註冊會計師事務所的報告 普華永道會計師事務所 在 康涅狄格州斯坦福德 （PCAOB ID 238).

◦2024年，2023年和2022年截至9月30日的綜合收益和綜合收益綜合表。

◦截至2024年和2023年9月30日的合併資產負債表。

◦截至2024年、2023年和2022年9月30日的合併現金流量表。

◦2021年10月1日至2024年9月30日股東權益變動表。

◦基本報表附註。

2)財務報表附表。

附表二 - 估值和合格帳戶包含在原始10-K表的項目15. 基本報表和補充數據中。

3)附件。

1

---

附件描述

展覽編號			展覽
2.1****			公司與energizer holdings, inc.之間的分拆和分配協議日期爲2015年6月25日（參見提交於2015年6月29日的公司第8-k表格上的附件2.1）
2.2****			公司與energizer holdings, inc.之間的稅務事項協議日期爲2015年6月26日（參見提交於2015年6月29日的公司第8-k表格上的附件2.2）
2.3****			公司與energizer holdings, inc.之間的員工事項協議日期爲2015年6月25日（參見提交於2015年6月29日的公司第8-k表格上的附件2.3）
2.4****			公司與energizer holdings, inc.之間的過渡服務協議日期爲2015年6月25日（參見提交於2015年6月29日的公司第8-k表格上的附件2.4）
2.5****			公司與energizer holdings, inc.之間的出資協議日期爲2015年6月30日（參見提交於2015年7月1日的公司第8-k表格上的附件2.1）
2.6			edgewell personal care公司、callahan corp.、harry's inc.和個別作爲股東代表的當事人之間的合併協議和計劃日期爲2019年5月8日（參見提交於2019年5月13日的公司第8-k表格上的附件2.1）
2.7			專門用於第13.17節的edgewell personal care公司的會員權益購買協議，edgewell personal care，LLC，Cremo Holding Company，LLC，其中命名的賣方，以及日期爲2020年8月1日的聯合持有人代表。
3.1			公司的修訂和重置公司章程（依據提交的文檔3.1，根據公司截至2013年12月31日季度報告在表格10-Q中的解釋）。
3.2			2015年6月30日生效的合併公約（依據提交的文檔3.1，根據公司於2015年7月1日提交的表格8-k中的解釋）。
3.3			公司的修訂和重置公司章程有效日期爲2020年11月5日（依據提交的文檔3.3，根據公司於2020年11月20日提交的表格10-k中的解釋）。
4.1			2011年5月19日生效的債券契約，由公司，其中命名的擔保人，以及信託公司紐約梅隆銀行，作爲受託人簽署（根據公司於2011年5月19日提交的表格8-k中的文檔4.1）。
4.2			第一份補充債券契約，日期爲2011年5月19日，由公司，其中命名的擔保人，以及紐約梅隆銀行信託公司，N.A.，作爲受託人簽署（根據公司於2011年5月19日提交的表格8-k中的文檔4.2）。
4.3			第二份補充債券契約（包括票據形式），日期爲2012年5月24日，由公司，其中命名的擔保人，以及紐約梅隆銀行信託公司，N.A.，作爲受託人簽署（根據公司於2012年5月24日提交的表格8-k中的文檔4.2）。
10.1			2015年6月1日的授信協議，由公司作爲借款人，JPMorgan Chase銀行，N.A.作爲管理代理人，以及美國銀行，N.A.，紐約梅隆銀行，東京三菱聯合金融銀行，有限公司，以及花旗銀行，N.A.，作爲共同銀團代理簽署（根據公司於2015年6月1日提交的表格8-k中的文檔10.1）。
10.2			關於2015年9月25日日前公司提出的《第1號全案修正案對信貸協議和附屬擔保做出部分修改》，其中有關方包括借款人Edgewell個人護理公司，新的子公司借款人Edgewell個人護理品牌有限責任公司，Edgewell的若干其他子公司作爲附屬擔保人，摩根大通銀行作爲行政代理，美國銀行，日本三菱東京日聯銀行及花旗銀行作爲共同組合代理，以及各方貸款人（參見《2015年9月29日提交的公司第8-k號當前報告附件10.1》）引用組成。
10.3			關於2016年4月29日日前公司提出的《信貸協議第2號修正案對Edgewell個人護理公司等所做修正》中有關方包括借款人Edgewell個人護理公司，子公司借款人Edgewell個人護理品牌有限責任公司，Edgewell個人護理公司的若干其他子公司作爲附屬擔保人，摩根大通銀行作爲行政代理，以及各方貸款人（參見《2016年4月29日提交的公司第8-k號當前報告附件10.1》）引用組成。
10.4			關於2017年3月13日日前公司提出的《信貸協議第3號修正案》對其中有關方包括借款人Edgewell個人護理公司，子公司借款人Edgewell個人護理品牌有限責任公司，Edgewell個人護理公司的若干其他子公司作爲附屬擔保人，摩根大通銀行作爲行政代理，美國銀行作爲聯合代理，以及各方貸款人（參見《2017年3月14日提交的公司第8-k號當前報告附件10.1》）引用組成。
10.5			關於2017年3月13日日前公司提出的《增加貸款方補充文件》，其中有關方包括增加貸款方日本三菱東京日聯銀行，借款人Edgewell個人護理公司，摩根大通銀行作爲行政代理（參見《2017年3月14日提交的公司第8-k號當前報告附件10.2》）引用組成。

---

10.6			Credit Agreement by and among Edgewell Personal Care Netherlands B.V., as borrower, the Company, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed June 15, 2015).
10.7			Amendment No. 1 dated as of September 25, 2015 to Credit Agreement by and among Edgewell Personal Care Netherlands B.V., Edgewell Personal Care Company, the institutions listed on the signature pages thereto and the Bank of Tokyo-Mitsubishi UFJ, Ltd., as the administrative agent for the lenders referred to therein (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed September 29, 2015).
10.8			Master Accounts Receivable Purchase Agreement dated as of September 15, 2017 among Edgewell Personal Care, LLC, as the Seller, Edgewell Personal Care Company, as Guarantor, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Purchaser (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed September 19, 2017).
10.9			Sixth Amendment to Master Accounts Receivable Purchase Agreement, dated as of February 7, 2022, between the Company and MUFG Bank, Ltd. (incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2022).
10.10			Seventh Amendment to Master Accounts Receivable Purchase Agreement, dated as of August 5, 2024, between the Company and MUFG Bank, Ltd (incorporated by reference to Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q filed on August 6, 2024).
10.11			Credit Agreement, dated as of March 28, 2020, by and among, inter alia, the Company, the subsidiaries of the Company from time to time parties thereto, the lenders from time to time parties thereto, MUFG, as syndication agent, TD as joint lead arranger and BofA, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 2, 2020).
10.12			Restatement Agreement, dated as of April 2, 2024, among Edgewell Personal Care Company, each of the guarantors party thereto, Bank of America, N.A., as Administrative Agent, the Issuing Bank and each Refinancing Lender party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed April 2, 2024).
10.13			Indenture, dated as of May 22, 2020, among Edgewell Personal Care Company, the guarantors party thereto and the Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed May 22, 2020.
10.14			Indenture, dated as of March 8, 2021, among Edgewell Personal Care Company, the guarantors party thereto and the Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed March 8, 2021).
10.15			Trademark License Agreement by and between the Company and Energizer Brands, LLC dated June 25, 2015 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed June 29, 2015).
10.16			Trademark License Agreement by and between the Company and Wilkinson Sword GmbH, as licensors, and Energizer Holdings, Inc. dated June 25, 2015 (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed June 29, 2015).
10.17			Tax Sharing Agreement (incorporated by reference to Exhibit 2.2 of the Company’s Post-Effective Amendment No. 1 to Form 10, filed April 19, 2000).
10.18***			A Summary of the Company's director compensation program (incorporated by reference to the Company's Definitive Proxy Statement for the fiscal year ended September 30, 2016).
10.19***			Form of Indemnification Agreement (for directors with existing agreements) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed May 28, 2015).
10.20***			Form of Indemnification Agreement (for new directors) (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed May 28, 2015).
10.21***			Second Amended and Restated 2009 Incentive Stock Plan (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2013).
10.22***			Form of Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed July 10, 2015).
10.23***			Form of Change of Control Agreement with certain Executive Officers (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed May 2, 2017).
10.24***			January 1, 2015 Restatement of the Company's Executive Savings Investment Plan (incorporated by reference to Exhibit 10.21 to the Company's Annual Report on Form 10-K for the year ended September 30, 2015).
10.25***			Amendment to the Company's Executive Savings Investment Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.12 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.26***			2010 Restatement of the Company's Supplemental Executive Retirement Plan dated October 15, 2010 (incorporated by reference to Exhibit 10.54 of Amendment No. 1 to the Company's Annual Report on Form 10-K/A, filed May 16, 2011).

---

10.27***			First Amendment to the 2010 Restatement of the Company's Supplemental Executive Retirement Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.24 to the Company's Annual Report on Form10-K for the year ended September 30, 2015).
10.28***			Second Amendment to the 2010 Restatement of the Company's Supplemental Executive Retirement Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.13 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.29***			2009 Restatement of the Company's Deferred Compensation Plan, as amended and restated effective as of January 1, 2009 (incorporated by reference to Exhibit 10 of the Company's Annual Report on Form 10-K for the year ended September 30, 2008).
10.30***			First Amendment to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to Exhibit 4.3 to the Company's Registration Statement on Form S-8 filed November 21, 2012).
10.31***			Amendment No. 2 to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to Exhibit 4.4 to the Company's Registration Statement on Form S-8 filed November 21, 2012).
10.32***			Amendment No. 3 to 2009 Restatement of the Company's Deferred Compensation Plan, dated November 7, 2011 (incorporated by reference to Exhibit 10.59 to the Company's Annual Report on Form 10-K for the year ended September 30, 2012).
10.33***			Amendment No. 4 to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to Exhibit 10.60 to the Company's Annual Report on Form 10-K for the year ended September 30, 2012).
10.34***			Amendment to the 2009 Restatement of the Company's Deferred Compensation Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.14 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.35***			Executive Group Personal Excess Liability Insurance Plan (incorporated by reference to Exhibit 10.9 of the Company's Post-Effective Amendment No. 1 to Form 10, filed April 19, 2000).
10.36***			Amended and Restated Executive Officer Bonus Plan (incorporated by reference to Exhibit 10.36 to the Company's Annual Report on Form 10-K for the year ended September 30, 2016).
10.37***			2017 Edgewell Personal Care Company Financial Planning Plan (incorporated by reference to Exhibit 10.39 to the Company's Annual Report on Form 10-K for the year ended September 30, 2017.
10.38***			Edgewell Personal Care Company Executive Severance Plan (incorporated by reference to Exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2017).
10.39***			Edgewell Personal Care Company Change in Control Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed May 1, 2019).
10.40***			Separation and General Release Agreement entered into on October 6, 2023 by and between John N. Hill and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed October 11, 2023).
10.41***			Separation and General Release Agreement entered into on July 31, 2024 by and between Eric O'Toole and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed August 6, 2024).
10.42***			Employment Offer Letter, dated November 7, 2024 by and between Francesca Weissman and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.42 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
10.43***			Employment Offer Letter, dated October 31, 2024 by and between Daniel Sullivan and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.43 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
10.44*/***			Edgewell Personal Care Company 2nd Amended and Restated 2018 Stock Incentive Plan
19.1*			Edgewell Personal Care Company Insider Trading Policy.
21.1			Subsidiaries of Registrant (incorporated by reference to Exhibit 21.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
23.1			Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm (incorporated by reference to Exhibit 23.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
31.1			Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 31.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
31.2			Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 31.2 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).

---

31.3*			Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.4*			Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 32.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
32.2			Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 32.2 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
97.1*			Edgewell Personal Care Company Compensation Recovery Policy.
101*			The following materials from the Edgewell Personal Care Company Annual Report on Form 10-K formatted in inline eXtensible Business Reporting Language (iXBRL): (i) the Consolidated Statements of Earnings and Comprehensive Income for the years ended September 30, 2022, 2023 and 2024, (ii) the Consolidated Balance Sheets at September 30, 2023 and 2024, (iii) the Consolidated Statements of Cash Flows for the years ended September 30, 2022, 2023 and 2024, (iv) Consolidated Statements of Changes in Shareholders’ Equity for the period from October 1, 2021 to September 30, 2024, and (v) Notes to Consolidated Financial Statements for the year ended September 30, 2024.
104*			Cover Page Interactive Data File (cover page XBRL tags are embedded within the Inline XBRL document).

 

*Filed herewith.

**Furnished herewith.

***Denotes a management contract or compensatory plan or arrangement.

****The Company hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement to the Securities and Exchange Commission upon request.

---

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			EDGEWELL PERSONAL CARE COMPANY
			By:			/s/ Rod R. Little
						Rod R. Little
						President and Chief Executive Officer

Date: November 21, 2024